Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences

Wednesday, September 6, 2017 6:50 am EDT

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two investor conferences in September as follows:

Conference:     Morgan Stanley 15th Annual Global Healthcare Conference
Date: Wednesday, September 13, 2017
Time: 8:45 a.m. Eastern Daylight Time
Location: Grand Hyatt New York, New York
Webcast:

https://cc.talkpoint.com/morg007/091117a_as/?entity=116_JT6RUVG

 
Conference:     Cantor Fitzgerald Global Healthcare Conference
Date: Monday, September 25, 2017
Time: 9:10 a.m. Eastern Daylight Time
Location: InterContinental New York Barclay Hotel, New York
Webcast:

http://wsw.com/webcast/cantor6/egrx

 

The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.

Contact:

Investor Relations for Eagle Pharmaceuticals, Inc:
In-Site Communications, Inc
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com